Abstract:Background The spread of disease related to hepatitis B and C poses a significant public health problem. There have been a few studies that examine the effects of cohort and period on the trend of mortality caused by hepatitis B and C. This analysis aims to use an Age–Period–Cohort framework to explore trends in mortality attributed to hepatitis B and C worldwide and in different socio‐demographic index (SDI) regions between 1990 and 2019. Methods The data for this analysis were taken from the Global Burden of Disease (GBD) study, which was used to perform an age–period–cohort analysis. The age effects reflect differences in exposure to risk factors at different stages of life. The period effects reflect population‐wide exposures at a circumscribed year. The cohort effects indicate different risks across birth cohorts. The results of the analysis include both the net drift and local drift, which are reported as the annual percentage change and that by age group. Results The age‐standardized mortality rate (ASMR) for hepatitis B declined from 12.36 to 6.74 per 100,000, and for hepatitis C from 8.45 to 6.67 per 100,000 between 1990 and 2019. The net drifts in mortality were −2.41% (95% CI −2.47 to −2.34) for hepatitis B and −1.16% (95% CI, −1.23 to –1.09) for hepatitis C, with negative local drifts in most age groups. Mortality from hepatitis B increased with age until 50+ years, while mortality from hepatitis C rose steadily with age. The period effect for hepatitis B was profound, suggesting effective national efforts in controlling the disease and the need for similar programs for hepatitis B and C. Mortality varied across the world and had moderate to weak negative correlations with the SDI, which substantially decreases in the High‐middle and Middle SDI regions, but has persistently high rates in the low SDI region. Conclusion Global efforts to manage hepatitis B and C have shown positive trends, but variations in trends were observed across regions with divergent age, cohort, and period effects. The national efforts of a comprehensive strategy are crucial to further strengthen the elimination of hepatitis B and C. This article is protected by copyright. All rights reserved.

[Research progress on the comorbidity between hepatitis B virus infection and noncommunicable diseases].

Research progress of the impact of nonalcoholic fatty liver disease on chronic hepatitis B infection

Increasing Age and Nonliver Comorbidities in Patients with Chronic Hepatitis B in Taiwan: A Nationwide Population-Based Analysis

Hepatitis B and C Virus Infection and Hepatocellular Carcinoma in China: A Review of Epidemiology and Control Measures

Disease Burden of Chronic Hepatitis B and Complications in China from 2006 to 2050: an Individual-Based Modeling Study

Chronic Hepatitis B and Non‐alcoholic Fatty Liver Disease: Conspirators or Competitors?

Advances in research of multimorbidity among HIV-positive individuals

Shifting Demographics and Comorbidity Burden in Adult Chinese Urban Patients with Chronic Hepatitis B, 2013 and 2016.

Epidemiological and Clinical Characteristics of 70 Cases of Coronavirus Disease and Concomitant Hepatitis B Virus Infection: A Multicentre Descriptive Study

Clinical Impact and Mechanisms of Hepatitis B Virus Infection Concurrent with Non-Alcoholic Fatty Liver Disease

Current challenges and the management of chronic hepatitis C in mainland China.

Changing Epidemiology of Hepatitis B Virus and Hepatitis C Virus Coinfection in a Human Immunodeficiency Virus–Positive Population in China: Results From the Third and Fourth Nationwide Molecular Epidemiologic Surveys

Research Progress of the Relationship Between HBV and NHL

HBV/HIV Coinfection: Impact on the Development and Clinical Treatment of Liver Diseases

Clinical Characteristics and Current Management of Hepatitis B and C in China.

Current Advances in the Elimination of Hepatitis B in China by 2030

Current hepatitis B treatment guidelines and future research directions

Factors Associated with Disease Progression and Viral Replication in Patients with Chronic Hepatitis B Virus Infection

Trends of Global Burden Related to HBV and HCV from 1990 to 2019: An Age–Period–Cohort Analysis

Clinical Research Advances in Chronic Hepatitis B Complicated by Fatty Liver Disease

Assessing the impact of comorbid type 2 diabetes mellitus on the disease burden of chronic hepatitis B virus infection and its complications in China from 2006 to 2030: a modeling study